Related Experiment Videos

Effects of thiabendazole on the kidneys of ICR mice

Y Tada1, M Yoneyama, J Kabashima

  • 1Department of Toxicology, Tokyo Metropolitan Research Laboratory of Public Health, Japan.

Insights

Thiabendazole (TBZ) administration in mice increased urine volume and affected kidney structure, indicating potential renal toxicity. These findings highlight TBZ

Area of Science:

  • Nephrology
  • Toxicology
  • Pharmacology

Background:

  • Thiabendazole (TBZ) is an anthelmintic drug.
  • Understanding TBZ's renal effects is crucial for safety assessment.

Purpose of the Study:

  • To investigate the effects of TBZ on mouse kidneys.
  • To characterize the dose- and time-dependent renal changes induced by TBZ.

Main Methods:

  • Male and female ICR mice were administered varying doses of TBZ (0, 250, 500 mg/kg/day) via gavage for 1-7 days.
  • Urine volume, protein content, serum markers (urea nitrogen, creatinine), relative kidney weights, and kidney histology (light and electron microscopy) were analyzed.

Main Results:

  • TBZ increased 24-hour urine volume, particularly in high-dose males, and induced high-molecular-weight proteinuria.
  • Relative kidney weights increased dose-dependently, with observed kidney swelling and white maculae.
  • Histopathology revealed tubular dilation, epithelial degeneration, podocyte foot process effacement, and mesangial edema, suggesting impaired water reabsorption.

Conclusions:

  • TBZ administration causes significant renal alterations in mice, including tubular and glomerular damage.
  • The observed increase in urine volume is likely due to impaired water reabsorption in renal tubules.
  • These findings indicate that TBZ exerts nephrotoxic effects in ICR mice.

Related Concept Videos